594 related articles for article (PubMed ID: 16739989)
1. Different immunoaffinity fractionation strategies to characterize the human plasma proteome.
Gong Y; Li X; Yang B; Ying W; Li D; Zhang Y; Dai S; Cai Y; Wang J; He F; Qian X
J Proteome Res; 2006 Jun; 5(6):1379-87. PubMed ID: 16739989
[TBL] [Abstract][Full Text] [Related]
2. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project.
Li X; Gong Y; Wang Y; Wu S; Cai Y; He P; Lu Z; Ying W; Zhang Y; Jiao L; He H; Zhang Z; He F; Zhao X; Qian X
Proteomics; 2005 Aug; 5(13):3423-41. PubMed ID: 16052619
[TBL] [Abstract][Full Text] [Related]
3. Reversed-phase high-performance liquid chromatographic prefractionation of immunodepleted human serum proteins to enhance mass spectrometry identification of lower-abundant proteins.
Martosella J; Zolotarjova N; Liu H; Nicol G; Boyes BE
J Proteome Res; 2005; 4(5):1522-37. PubMed ID: 16212403
[TBL] [Abstract][Full Text] [Related]
4. Efficient prefractionation of low-abundance proteins in human plasma and construction of a two-dimensional map.
Cho SY; Lee EY; Lee JS; Kim HY; Park JM; Kwon MS; Park YK; Lee HJ; Kang MJ; Kim JY; Yoo JS; Park SJ; Cho JW; Kim HS; Paik YK
Proteomics; 2005 Aug; 5(13):3386-96. PubMed ID: 16047310
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of human plasma proteins by two-dimensional gel electrophoresis and by antibody arrays following depletion of high-abundance proteins.
Desrosiers RR; Beaulieu E; Buchanan M; Béliveau R
Cell Biochem Biophys; 2007; 49(3):182-95. PubMed ID: 17952643
[TBL] [Abstract][Full Text] [Related]
6. Multi-component immunoaffinity subtraction and reversed-phase chromatography of human serum.
Martosella J; Zolotarjova N
Methods Mol Biol; 2008; 425():27-39. PubMed ID: 18369884
[TBL] [Abstract][Full Text] [Related]
7. Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes.
Faca V; Pitteri SJ; Newcomb L; Glukhova V; Phanstiel D; Krasnoselsky A; Zhang Q; Struthers J; Wang H; Eng J; Fitzgibbon M; McIntosh M; Hanash S
J Proteome Res; 2007 Sep; 6(9):3558-65. PubMed ID: 17696519
[TBL] [Abstract][Full Text] [Related]
8. Application of 2-D free-flow electrophoresis/RP-HPLC for proteomic analysis of human plasma depleted of multi high-abundance proteins.
Moritz RL; Clippingdale AB; Kapp EA; Eddes JS; Ji H; Gilbert S; Connolly LM; Simpson RJ
Proteomics; 2005 Aug; 5(13):3402-13. PubMed ID: 16052629
[TBL] [Abstract][Full Text] [Related]
9. Comparison of protein enrichment strategies for proteome analysis of plasma.
Bandow JE
Proteomics; 2010 Apr; 10(7):1416-25. PubMed ID: 20127685
[TBL] [Abstract][Full Text] [Related]
10. Multicolumn separation platform for simultaneous depletion and prefractionation prior to 2-DE for facilitating in-depth serum proteomics profiling.
Jmeian Y; El Rassi Z
J Proteome Res; 2009 Oct; 8(10):4592-603. PubMed ID: 19670910
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of three principally different intact protein prefractionation methods for plasma biomarker discovery.
Pernemalm M; Orre LM; Lengqvist J; Wikström P; Lewensohn R; Lehtiö J
J Proteome Res; 2008 Jul; 7(7):2712-22. PubMed ID: 18549256
[TBL] [Abstract][Full Text] [Related]
12. Depletion of high-abundance proteins in plasma by immunoaffinity subtraction for two-dimensional difference gel electrophoresis analysis.
Dardé VM; Barderas MG; Vivanco F
Methods Mol Biol; 2007; 357():351-64. PubMed ID: 17172701
[TBL] [Abstract][Full Text] [Related]
13. Combination of affinity depletion of abundant proteins and reversed-phase fractionation in proteomic analysis of human plasma/serum.
Zolotarjova N; Mrozinski P; Chen H; Martosella J
J Chromatogr A; 2008 May; 1189(1-2):332-8. PubMed ID: 18154976
[TBL] [Abstract][Full Text] [Related]
14. Limitation of immunoaffinity column for the removal of abundant proteins from plasma in quantitative plasma proteomics.
Ichibangase T; Moriya K; Koike K; Imai K
Biomed Chromatogr; 2009 May; 23(5):480-7. PubMed ID: 19039805
[TBL] [Abstract][Full Text] [Related]
15. Depletion of the high-abundance plasma proteins.
Fountoulakis M; Juranville JF; Jiang L; Avila D; Röder D; Jakob P; Berndt P; Evers S; Langen H
Amino Acids; 2004 Dec; 27(3-4):249-59. PubMed ID: 15592754
[TBL] [Abstract][Full Text] [Related]
16. High-abundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins.
Bellei E; Bergamini S; Monari E; Fantoni LI; Cuoghi A; Ozben T; Tomasi A
Amino Acids; 2011 Jan; 40(1):145-56. PubMed ID: 20495836
[TBL] [Abstract][Full Text] [Related]
17. Effect of immunoaffinity depletion of human serum during proteomic investigations.
Yocum AK; Yu K; Oe T; Blair IA
J Proteome Res; 2005; 4(5):1722-31. PubMed ID: 16212426
[TBL] [Abstract][Full Text] [Related]
18. Two-dimensional liquid chromatography/tandem mass spectrometry analysis of Gradiflow fractionated native human plasma.
Wasinger VC; Locke VL; Raftery MJ; Larance M; Rothemund D; Liew A; Bate I; Guilhaus M
Proteomics; 2005 Aug; 5(13):3397-401. PubMed ID: 16104060
[TBL] [Abstract][Full Text] [Related]
19. A novel four-dimensional strategy combining protein and peptide separation methods enables detection of low-abundance proteins in human plasma and serum proteomes.
Tang HY; Ali-Khan N; Echan LA; Levenkova N; Rux JJ; Speicher DW
Proteomics; 2005 Aug; 5(13):3329-42. PubMed ID: 16052622
[TBL] [Abstract][Full Text] [Related]
20. Analysis of human serum by liquid chromatography-mass spectrometry: improved sample preparation and data analysis.
Govorukhina NI; Reijmers TH; Nyangoma SO; van der Zee AG; Jansen RC; Bischoff R
J Chromatogr A; 2006 Jul; 1120(1-2):142-50. PubMed ID: 16574134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
